It is also known for its inhibitory effect on NFκB activity, thereby re-sensitizing diffuse large B-cell lymphoma and primary chronic lymphocytic leukemia cells to extrinsic apoptosis [197]. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.